Delivery Order SPE2DB24D2205-SPE2DB25FEFJF
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count), a combination respiratory medication used to treat chronic obstructive pulmonary disease. Valued at $7,519.59 with firm fixed pricing, this non-set-aside delivery order is scheduled for completion by August 27, 2025, with performance at the vendor's Conshohocken, Pennsylvania location. This delivery order represents one...
- The Defense Logistics Agency awarded a $14,531.57 delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units), a combination respiratory medication used primarily in chronic obstructive pulmonary disease management. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalers (60-count units) with a ceiling value of $1,867.66 and an ultimate completion date of August 1, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made...
- The Defense Logistics Agency awarded a $12,545.94 delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 inhalers (60-count units) on July 31, 2025, with an ultimate completion date of August 1, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalers (60-count units) valued at $101,693.21. This firm fixed-price delivery order, with an ultimate completion date of August 7, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside designation. Trelegy...
- The Defense Logistics Agency awarded a delivery order valued at $4,156.54 to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by July 28, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count) on September 24, 2025, with a ceiling value of $26,026.55. This is a firm fixed-price delivery order with no set-aside designation, executed as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is the vendor's corporate office in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a delivery order valued at $3,415.62 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 inhalers (60-count units) on July 14, 2025, with completion expected by July 15, 2025. This firm fixed price delivery order represents a non-competitive award under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999.999 billion through December 2026. The product is being delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $18,103.28 to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 inhaler, a combination respiratory medication used to treat chronic obstructive pulmonary disease. This firm fixed price delivery order was awarded on August 12, 2025, with an ultimate completion date of August 13, 2025, and represents a non-competitive award under the company's existing contract vehicle. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Trelegy Ellipta 100-62.5-25 60S, a combination respiratory medication, with a ceiling value of $8,524.93. This firm fixed price delivery order, which is not set-aside designated, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The ultimate completion...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEFJFDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count), a combination respiratory medication used to treat chronic obstructive pulmonary disease. This firm fixed-price delivery order, valued at $17,534.94, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award carries no set-aside designation and was competitively awarded. Performance will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, supplying military and veteran healthcare systems with a comprehensive range of brand-name and generic medications, vaccines, and medical devices. The company's broader DLA contract vehicle enables it to deliver pharmaceutical products globally to support Defense Health Agency operations, the U.S. Coast Guard, and other government healthcare systems. This delivery order is scheduled for completion by July 25, 2025, and exemplifies the vendor's ongoing role as a primary supplier of specialty medications and medical commodities to the federal healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.5k | 7/24/25 |